Legis Daily

Ensuring Sufficient Supply of Testing Act

USA118th CongressHR-3840| House 
| Updated: 6/9/2023
Neal P. Dunn

Neal P. Dunn

Republican Representative

Florida

Cosponsors (1)
Debbie Dingell (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Ensuring Sufficient Supply of Testing Act This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies. Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 6, 2023
Introduced in House
Jun 6, 2023
Referred to the House Committee on Energy and Commerce.
Jun 9, 2023
Referred to the Subcommittee on Health.
  • June 6, 2023
    Introduced in House


  • June 6, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 9, 2023
    Referred to the Subcommittee on Health.

Health

Health technology, devices, suppliesMedical tests and diagnostic methodsPublic contracts and procurementStrategic materials and reserves

Ensuring Sufficient Supply of Testing Act

USA118th CongressHR-3840| House 
| Updated: 6/9/2023
Ensuring Sufficient Supply of Testing Act This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies. Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 6, 2023
Introduced in House
Jun 6, 2023
Referred to the House Committee on Energy and Commerce.
Jun 9, 2023
Referred to the Subcommittee on Health.
  • June 6, 2023
    Introduced in House


  • June 6, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 9, 2023
    Referred to the Subcommittee on Health.
Neal P. Dunn

Neal P. Dunn

Republican Representative

Florida

Cosponsors (1)
Debbie Dingell (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health technology, devices, suppliesMedical tests and diagnostic methodsPublic contracts and procurementStrategic materials and reserves